Aripiprazole is an atypical antipsychotic API widely used in the treatment of schizophrenia, bipolar disorder, major depressive disorder, and autism-related irritability.
It acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors, offering a unique pharmacological profile with fewer side effects than typical antipsychotics.

At Bluepill Express, Aripiprazole is manufactured under WHO-GMP and cGMP-certified facilities, ensuring superior purity, precise particle size distribution, and global regulatory compliance.

Therapeutic Category

• Antipsychotic (Atypical)
• Mood Stabilizer
• Antidepressant Adjunct

Mechanism of Action

Aripiprazole works by modulating dopamine and serotonin activity in the brain.
It functions as a dopamine-serotonin system stabilizer, balancing neurotransmission to alleviate symptoms such as hallucinations, delusions, mood swings, and depression. This mechanism results in effective symptom control with minimal extrapyramidal side effects.

Chemical Information

Physical & Chemical Properties

Technical Specifications (Typical Bluepill Express Standard)

Pharmacological Applications

• Schizophrenia: Reduces positive and negative symptoms with lower sedation and metabolic side effects.
• Bipolar Disorder: Stabilizes mood swings and prevents manic or depressive episodes.
• Major Depressive Disorder (Adjunct): Enhances antidepressant efficacy when used with SSRIs or SNRIs.
• Autism Spectrum Disorder: Helps control irritability, aggression, and repetitive behavior.

Packaging & Export Details

Documentation Supplied

• Certificate of Analysis (COA)
• Material Safety Data Sheet (MSDS)
• Technical Data Sheet (TDS)
• Stability Data (as per ICH Q1A)
• Regulatory Support (DMF/CTD on request)